Utilization of duloxetine and celecoxib in osteoarthritis patients

References

• Osteoarthritis. Centers for Disease Control and Prevention. 2010. Available at: http://www.cdc.gov/arthritis/basics/osteoarthritis.htm [Last accessed 22 July 2012]
   Google Scholar
• Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and rheumatism 2008;58:26-35
   PubMed Web of Science ®Google Scholar
• Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and rheumatism 2008;58:15-25
   PubMed Web of Science ®Google Scholar
• Laurencin CT, Khan Y, Kofron M, et al. The ABJS Nicolas Andry Award: tissue engineering of bone and ligament: a 15-year perspective. Clin Orthop Relat Res 2006;447:221-36
   PubMedGoogle Scholar
• American Academy of Orthopaedic Surgeons. United States Bone and Joint Decade: The Burden of Musculoskeletal Diseases in the United States. 2008. Available at: http://www.boneandjointburden.org/ [Last accessed 10 January 2012]
   Google Scholar
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Richmond J, Hunter D, Irrgang J, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am 2010;92:990-3
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093-9
   PubMed Web of Science ®Google Scholar
• Howes F, Buchbinder R, Winzenberg TB. Opioids for osteoarthritis? Weighing benefits and risks: a Cochrane Musculoskeletal Group review. J Fam Pract 2011;60:206-12
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Deyo RA, Mirza SK, Turner JA, et al. Overtreating chronic back pain: time to back off? J Am Board Fam Med 2009;22:62-8
   PubMed Web of Science ®Google Scholar
• Gore M, Sadosky AB, Leslie DL, et al. Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain. Pain Pract 2012;12:457-68
   PubMed Web of Science ®Google Scholar
• Bernacki EJ, Yuspeh L, Lavin R, et al. Increases in the use and cost of opioids to treat acute and chronic pain in injured workers, 1999 to 2009. J Occup Environ Med 2012;54:216-23
   PubMed Web of Science ®Google Scholar
• Vogt MT, Kwoh CK, Cope DK, et al. Analgesic usage for low back pain: impact on health care costs and service use. Spine 2005;30:1075-81
   PubMed Web of Science ®Google Scholar
• Contreras-Hernandez I, Mould-Quevedo JF, Torres-Gonzalez R, et al. Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors. Cost Effectiveness and Resource Allocation 2008;6:1-13
   PubMedGoogle Scholar
• Cymbalta [package insert]. 2010. Available at: http://pi.lilly.com/us/cymbalta-pi.pdf [Last accessed 24 July 2012]
   Google Scholar
• Iyengar S, Webster AA, Hemrick-Luecke SK, et al. Efficacy of duloxetine, a potent and balanced serotonin–norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Therapeut 2004;311:576-84
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008;11(2 Suppl):S63-88
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010;13:401-35
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9-38
   PubMed Web of Science ®Google Scholar
• Nuesch E, Rutjes AW, Husni E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;(4):CD003115
   PubMedGoogle Scholar
• Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006;81:103-7
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27
   PubMed Web of Science ®Google Scholar
• Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;(1):CD004257
   PubMed Web of Science ®Google Scholar
• Caldwell B, Aldington S, Weatherall M, et al. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006;99:132-40
   PubMed Web of Science ®Google Scholar
• Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42
   PubMed Web of Science ®Google Scholar
• Abou-Raya S, Abou-Raya A, Helmii M. Duloxetine for the management of pain in older adults with with knee osteoarthritis: randomised placebo-controlled trial. Age Ageing 2012;41:646-52
   PubMed Web of Science ®Google Scholar
• Micca JL, Ruff D, Ahl J, et al. Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a posthoc, subgroup analysis of two randomized, placebo-controlled trials. BMC Musculoskelet Disord 2013;14:1-7
   PubMedGoogle Scholar